Natco Pharma submits analyst meet intimation

25 Nov 2023 Evaluate
Natco Pharma has informed that it enclosed the disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The official(s) of the Company will be participating in the investor meetings: 28 to 29 November 2023. The schedule of the above-mentioned meetings is subject to change and the change may occur due to exigencies on the part of Investor/ Company. No Unpublished Price Sensitive Information (UPSI) is intended to be discussed during the interactions.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

1019.35 18.65 (1.86%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.95
Dr. Reddys Lab 1303.90
Cipla 1321.75
Zydus Lifesciences 912.95
Lupin 2344.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×